Core Viewpoint - The company anticipates a significant year-on-year increase in its overall product gross margin for the fiscal year 2025, driven by improvements in supply chain management, cost reduction, efficiency enhancement, and technological optimization [1] Group 1: Gross Margin Drivers - The increase in gross margin is attributed to the company's enhanced supply chain management and ongoing cost reduction initiatives [1] - Technological innovations and product structure optimization are also key factors contributing to the improvement in gross margin [1] Group 2: Product and Market Strategy - The company is focusing on differentiated competition strategies by launching high-performance products such as the Hiclaim® series and functionalized series of polyethers [1] - There is a gradual increase in the sales proportion of high-value-added products like specialty polyethers, which is supported by an optimized customer structure and deeper collaboration with strategic clients [1]

Core Viewpoint - The company, Huayuan Biological, is a major global producer of lanolin cholesterol and is committed to continuously optimizing its production processes and technologies to enhance its competitive advantage [2]. Company Summary - Huayuan Biological is recognized as one of the leading producers of lanolin cholesterol globally [2]. - The company is focused on improving its production techniques and technological capabilities [2].